增加2型糖尿病及相关血糖性状遗传研究的人群多样性
本文综述了2型糖尿病及相关血糖性状遗传研究中多祖先参与者纳入的进展与挑战。目前多数遗传研究基于欧洲血统个体,尽管全球代表性有所增加,但仍需进一步扩大 diverse 人群的纳入,以实现精准医学的承诺。
要点
- 当前2型糖尿病遗传研究多基于欧洲血统人群,全球代表性不足。
- 增加多祖先人群纳入对实现精准医学至关重要。
- 需克服便利样本带来的局限性,扩大遗传研究的全球多样性。
核心结论
- 遗传和基因组研究需增加全球多样性代表,才能实现惠及所有人的精准医学。
研究设计与样本
- 综述,讨论2型糖尿病及相关血糖性状遗传分析中多祖先参与者纳入的进展、机遇与挑战。
主要发现
- 流行病学数据显示部分人群2型糖尿病风险更高。
- 迄今为止,大多数2型糖尿病及相关血糖性状的遗传研究在欧洲血统个体中进行。
- 自2005年GWAS革命开始,多基于现有收集的便利样本进行快速基因分型。
- 过去15年全球代表性有所增加,但仍需进一步扩展和纳入多样化人群。
临床怎么用
- 在内分泌科临床与科研中,应关注遗传研究的 ancestry 多样性,避免将欧洲血统人群的遗传发现直接外推至其他人群。
局限性
- 原文未系统报告具体研究样本量、阈值或效应值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Type 2 diabetes has a global prevalence, with epidemiological data suggesting that some populations have a higher risk of developing this disease. However, to date, most genetic studies of type 2 diabetes and related glycaemic traits have been performed in individuals of European ancestry. The same is true for most other complex diseases, largely due to use of 'convenience samples'. Rapid genotyping of large population cohorts and case-control studies from existing collections was performed when the genome-wide association study (GWAS) 'revolution' began, back in 2005. Although global representation has increased in the intervening 15 years, further expansion and inclusion of diverse populations in genetic and genomic studies is still needed. In this review, I discuss the progress made in incorporating multi-ancestry participants in genetic analyses of type 2 diabetes and related glycaemic traits, and associated opportunities and challenges. I also discuss how increased representation of global diversity in genetic and genomic studies is required to fulfil the promise of precision medicine for all.
引用
- Barroso I. The importance of increasing population diversity in genetic studies of type 2 diabetes and related glycaemic traits. Diabetologia. 2021. PMID: 34595549. doi:10.1007/s00125-021-05575-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。